Literature DB >> 2344854

Clinical pharmacology and primary health care in Europe--a gap to bridge. The WHO Working Group on Clinical Pharmacology in Europe.

G Dukes1, P K Lunde, A Melander, M Orme, F Sjöqvist, G Tognoni, H Wesseling.   

Abstract

A group of senior European clinical pharmacologists presents a position paper on the possible role of clinical pharmacology (CP) in bridging the gap between academic drug evaluation and drug prescribing in primary health care (PHC). As a teaching, research and service discipline CP has developed in academic or other major hospitals while 80% of all drugs are prescribed in PHC. CP therefore has to extend its functions to PHC. Examples are given of how joint ventures between clinical pharmacologists and PHC physicians may improve the quality of drug research and increase the clinical relevance of drug information in PHC, thereby contributing towards rational drug utilization in PHC. Colleagues in PHC are invited to respond to this call for collaboration.

Mesh:

Year:  1990        PMID: 2344854     DOI: 10.1007/bf00315567

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  3 in total

1.  Clinical pharmacology in Europe: an indispensible part of the health service. WHO Working Group on Clinical Pharmacology in Europe.

Authors: 
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  The teaching and organisation of clinical pharmacology in European medical schools (W.H.O. Working Group on Clinical Pharmacology).

Authors:  M Orme; F Sjoqvist; J Bircher; M Bogaert; M N Dukes; M Eichelbaum; L F Gram; H Huller; I Lunde; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Clinical pharmacology scope, organization, training. Report of a WHO study group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1970
  3 in total
  14 in total

1.  Drug utilization in general practice: prescribing habits of National Formulary drugs by GPs of Emilia Romagna (Italy) in 1988 and 1989.

Authors:  N Montanaro; N Magrini; A Vaccheri; M Battilana
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Clinical pharmacology and the provision of drug information.

Authors:  B Ohman; H Lyrvall; E Törnqvist; G Alván; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  Clinical pharmacology in Europe. The WHO European Task Force on Clinical Pharmacology.

Authors:  M Orme; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  References used in a drug information centre.

Authors:  A Llerena; B Ohman; G Alván
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 5.  Postgraduate education in clinical pharmacology and therapeutics.

Authors:  J C Mucklow
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335

Review 6.  Prevalence of potentially inappropriate long term prescribing in general practice in the United Kingdom, 1980-95: systematic literature review.

Authors:  S A Buetow; B Sibbald; J A Cantrill; S Halliwell
Journal:  BMJ       Date:  1996-11-30

7.  Clinical Pharmacology in European health care-outcome of a questionnaire study in 31 countries.

Authors:  Michael Orme; Folke Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  2013-05-10       Impact factor: 2.953

8.  Efforts and success world-wide in the field of clinical pharmacology. A personal review on the occasion of Folke Sjöqvist's 80th birthday.

Authors:  Michael Orme
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

9.  Clinical pharmacology in everyday clinical care.

Authors:  Petra A Thürmann
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

10.  Prescription of drugs not listed in a clinic's pharmacopoeia: supervision by clinical pharmacologists.

Authors:  S Harder; P Thürmann; T Huber; N Rietbrock
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.